Neuroone Medical Technologies earnings were -$6.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest NMTC earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.1M, up 45.1% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, NMTC reported annual earnings of -$3.6M, with -70.7% growth.
Neuroone Medical Technologies Earnings Reports & History FAQ
What were Neuroone Medical Technologies's earnings last quarter?
Neuroone Medical Technologies (NASDAQ: NMTC) reported Q1 2026 earnings per share (EPS) of -$0.25, up 43.18% year over year. Total NMTC earnings for the quarter were -$2.09 million. In the same quarter last year, Neuroone Medical Technologies's earnings per share (EPS) was -$0.44.
Is Neuroone Medical Technologies profitable or losing money?
As of the last Neuroone Medical Technologies earnings report, Neuroone Medical Technologies is currently losing money. Neuroone Medical Technologies's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$6.64 million, a 0.61% increase year over year.
What was NMTC's earnings growth in the past year?
As of Neuroone Medical Technologies's earnings date in Q2 2026, Neuroone Medical Technologies's earnings has grown year over year. NMTC earnings in the past year totalled -$6.64 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.